Bin Wang

Dr. Bin Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2022 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
BWBin Wang
Bin Wang
WYWeidong Yao
Weidong Yao
QXQi Xue
Qi Xue
MWMingfang Wang
Mingfang Wang
JXJianling Xu
Jianling Xu
YZYe Zhang
Ye Zhang
Background: Accurate prediction of the difficult airway (DA) could help to prevent catastrophic consequences in emergency resuscitation, intensive care, and general anesthesia. Until now, there is no nomogram prediction model for DA based on ultrasound assessment. In this study, we aimed to develop a predictive model for difficult tracheal intubation (DTI) and difficult laryngoscopy (DL) using nomogram based on ultrasound measurement. We hypothesized that nomogram could utilize multivariate data to predict DTI and DL. Methods: A prospective observational DA study was designed. This study included 2254 patients underwent tracheal intubation. Common and airway ultrasound indicators were used for the prediction, including thyromental distance (TMD), modified Mallampati test (MMT) score, upper lip bite test (ULBT) score temporomandibular joint (TMJ) mobility and tongue thickness (TT). Univariate and the Akaike information criterion (AIC) stepwise logistic regression were used to identify independent predictors of DTI and DL. Nomograms were constructed to predict DL and DTL based on the AIC stepwise analysis results. Receiver operating characteristic (ROC) curves were used to evaluate the accuracy of the nomograms. Results: Among the 2254 patients enrolled in this study, 142 (6.30%) patients had DL and 51 (2.26%) patients had DTI. After AIC stepwise analysis, ULBT, MMT, sex, TMJ, age, BMI, TMD, IID, and TT were integrated for DL nomogram; ULBT, TMJ, age, IID, TT were integrated for DTI nomogram. The areas under the ROC curves were 0.933 [95% confidence interval (CI), 0.912–0.954] and 0.974 (95% CI, 0.954–0.995) for DL and DTI, respectively. Conclusion: Nomograms based on airway ultrasonography could be a reliable tool in predicting DA. Trial registration: Chinese Clinical Trial Registry (No. ChiCTR-RCS-14004539), registered on 13th April 2014.

22 October 2020 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
HCHong Chen
Hong Chen
BWBin Wang
Bin Wang
QLQin Li
Qin Li
JZJuan Zhou
Juan Zhou
RLRui Li
Rui Li
YZYe Zhang
Ye Zhang
Background: The catheter-related bladder discomfort (CRBD) of male patients is a common clinical problem, albeit lacking effective solutions. The present study aimed to investigate whether intravesical dexmedetomidine instillation alleviates the postoperative urinary discomfort in male patients with catheter under general anesthesia.Methods: This single-blinded, prospective, randomized study included a total of 167 male patients American Society of Anesthesiologists (ASA) physical status I-II scheduled for surgery under general anesthesia were allocated to two groups: 84 in the dexmedetomidine group and 83 in the control group. Dexmedetomidine group patients received intravesical instillation of the drug 0.5 μg/kg and normal saline 20 mL, while the control group received intravesical instillation of 20 mL normal saline. The catheter was clamped for 30 min after intravesical instillation for all patients. CRBD scores and urethra pain numerical rating scale (NRS) scores were measured at admittance to post-anesthesia care unit (PACU) (T0), intravesical instillation (T1), 30 min (T2), 60 min (T3), 2 h (T4) after intravesical instillation, discharged from PACU (T5), and 6 h (T6) and 24 h (T7) after the operation. Patient satisfaction at discharge from PACU and 24 h post-operation were compared between the two groups.Results: CRBD scores and urethra pain NRS scores after 30 min of intravesical dexmedetomidine instillation to 24 h post-operation were significantly lower than the control group (p < 0.001), and patient satisfaction was higher at discharge from PACU and 24 h post-operation (p < 0.001). No differences were detected in Steward score out of PACU (p = 0.213) and from the time of the end of operation to fully awake (p = 0.417).Conclusion: Intravesical dexmedetomidine instillation reduces postoperative urinary discomfort and urethra pain and improves satisfaction in male patients under general anesthesia.Trial registration: Chinese Clinical Trial Registry (No.ChiCTR1800016429), date of registration 1st June 2018.

30 September 2023 in Materials Advances
Verified
Journal Article
Open access
PDF file
XLXiaojun Li
Xiaojun Li
QWQi Wang
Qi Wang
QFQi Fang
Qi Fang
JXJianling Xu
Jianling Xu
BHBaosong Han
Baosong Han
BWBin Wang
Bin Wang
Targeted nanoparticles can be used to treat ischemic stroke by targeting the complex pathological mechanism of ischemic stroke and the blood–brain barrier that is difficult to penetrate by most traditional drugs.

12 February 2026 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
CDChu-Chu Du
Chu-Chu Du
WCWei Chen
Wei Chen
HWhao wang
hao wang
LGLing Guo
Ling Guo
BWBin Wang
Bin Wang
YCYongquan Chen
Yongquan Chen
Objective: This study aimed to evaluate the efficacy of fluid responsiveness-guided strategies for preventing spinal anesthesia-induced hypotension (SAIH) in parturients undergoing cesarean delivery, comparing prophylactic fluid loading with norepinephrine infusion. Methods: In this fluid responsiveness-based stratified randomized controlled trial, eligible parturients were stratified into fluid responsive (FR(+)) and non-fluid responsive (FR(-)) cohorts according to carotid corrected flow time (FTc). Each stratum had a preset sample size of 236, and within each stratum, participants were randomly assigned to receive either prophylactic colloid infusion (Co) or norepinephrine infusion (NE), ultimately forming four subgroups: FR(+)/Co, FR(+)/NE, FR(-)/Co, and FR(-)/NE.Primary outcomes included the incidence of SAIH and maximum reduction in mean arterial pressure (MAP). Secondary outcomes encompassed neonatal umbilical cord blood gas analysis, Apgar scores, intraoperative hemodynamic changes, and postoperative recovery parameters. Results: Among fluid-responsive parturients, prophylactic fluid loading (FR(+)/Co) and norepinephrine infusion (FR(+)/NE) demonstrated comparable efficacy in preventing SAIH (16.7% vs. 15.1%, P > 0.05). In contrast, non-fluid-responsive parturients receiving fluid loading (FR(-)/Co) had a significantly higher SAIH incidence (34.2%) compared to those receiving norepinephrine (FR(-)/NE, 13.6%, P = 0.0004). Neonatal umbilical cord blood lactate levels were higher in the FR(+)/NE group compared to the FR(+)/Co group (1.66 ± 0.25 mmol/L vs. 1.55 ± 0.28 mmol/L, P = 0.006), suggesting potential fetal hypoxia. Additionally, the FR(+)/NE group exhibited prolonged postoperative gastrointestinal recovery times compared to the FR(+)/Co group (29 [20, 39] h vs. 24 [16, 35] h, P = 0.0438). Conclusion: Fluid loading is optimal for fluid-responsive parturients, whereas norepinephrine infusion is superior for non-fluid-responsive parturients. These findings advocate for fluid responsiveness-guided individualized SAIH prevention strategies to optimize maternal and neonatal outcomes. Trial registration: This trial was prospectively registered at ClinicalTrials.gov (ChiCTR2400084392) on May 15, 2024, prior to participant enrollment.

31 March 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
JXJianling Xu
Jianling Xu
JZJingyong Zhou
Jingyong Zhou
XLXiaojun Li
Xiaojun Li
TQTingting Qu
Tingting Qu
CZChangjian Zheng
Changjian Zheng
BWBin Wang
Bin Wang
Background: Neuropathic pain (NP) is frequently accompanied by anxiety and depression, and current treatments do not adequately address this comorbidity. The anterior cingulate cortex (ACC) plays a central role in sensory and emotional processing. However, the molecular pathways that connect these functions remain unclear. G protein‐coupled receptor 35 (GPR35), an orphan receptor enriched in neurons, has been implicated in neuroinflammation and pain signaling. However, its specific involvement in NP and associated affective disturbances has not been fully elucidated. Methods: Peripheral blood GPR35 expression was measured in human patients with NP and healthy controls. In mice, chronic constriction injury (CCI) was used to induce NP. Lentiviral knockdown or overexpression of GPR35 was performed in ACC cells. Behavioral assays were used to assess mechanical and thermal sensitivity, locomotor and anxiety metrics, cognitive performance, and depression‐related behaviors. Molecular analyses included western blotting, RT‐qPCR, immunofluorescence, RNA sequencing, and co‐immunoprecipitation. Additional Nr4a1 knockdown and L‐kynurenine (L‐Kyna, a GPR35 agonist) administration were used to validate pathway involvement. Results: Patients with NP had higher circulating GPR35 levels, which positively correlated with pain intensity. CCI induced a time‐dependent increase in GPR35 expression in the ACC of mice, accompanied by hypersensitivity and emotional disturbances. GPR35 knockdown in the ACC worsens mechanical and thermal hypersensitivity, impairs cognition, increases depression‐related behaviors, and amplifies microglial activation and pro‐inflammatory cytokine production. GPR35 overexpression reversed these effects by reducing hypersensitivity, improving affective behaviors, and restoring the inflammatory balance. Transcriptomic and biochemical analyses identified Nr4a1 as a key downstream effector of GPR35, and Nr4a1 knockdown eliminated the protective effects of GPR35 overexpression. GPR35 primarily regulated the PI3K/AKT pathway. Treatment with L‐Kyna reduced pain hypersensitivity, improved depression‐related behaviors, and decreased neuroinflammation in CCI mice. Conclusions: GPR35 is an essential regulator of NP and pain‐related affective disturbances in the ACC. Its effects are mediated through the Nr4a1‐dependent activation of the PI3K/AKT pathway and suppression of neuroinflammation. The pharmacological activation of GPR35 using L‐Kyna provides analgesic and antidepressant benefits, highlighting GPR35 as a promising therapeutic target for NP and its emotional comorbidities.

10 February 2026 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
XLXiaojun Li
Xiaojun Li
QWQi Wang
Qi Wang
QCQingyu Cheng
Qingyu Cheng
JZJingyong Zhou
Jingyong Zhou
TQTingting Qu
Tingting Qu
BWBin Wang
Bin Wang
Ischemic stroke remains a leading cause of global mortality and disability. While timely vascular recanalization is the most direct and clinically validate